What is NDC 58160-955?

58160-955 is the product NDC for Menveo kit, listed with the FDA by GlaxoSmithKline Biologicals SA. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine).

GlaxoSmithKline Biologicals SA, NDC labeler code 58160. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Menveo?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Menveo NDC 58160-955 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)58160-955Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58160-0955Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
58160-955-09	58160095509	1 KIT in 1 CARTON (58160-955-09) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-958-01) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-959-01)Marketed from Mar 1, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Menveo
Generic name (nonproprietary): meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine
Dosage form: Kit
Labeler: GlaxoSmithKline Biologicals SANDC labeler code 58160
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 125300
Marketing start: Mar 1, 2017
Listing expires: Dec 31, 2027
Identifiers: Product ID 58160-955_ffd9ae2b-caa1-4753-86f2-fc7a8180ff79SPL ID ffd9ae2b-caa1-4753-86f2-fc7a8180ff79

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N458160095509 followed by a unit qualifier and the quantity

Package 58160-0955-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 58160-955

What is NDC 58160-955?: 58160-955 is the product NDC for Menveo kit, listed with the FDA by GlaxoSmithKline Biologicals SA. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine).
Who is the labeler?: GlaxoSmithKline Biologicals SA, NDC labeler code 58160. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Menveo?: 1 other product NDC are listed under this name. See all Menveo NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Menveo NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Menveomeningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine	Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen 10 ug/.5mL + 3 more ingredients	Injection, SolutionIntramuscular	GlaxoSmithKline Biologicals SA	58160-827	58160-0827-30

Other NDCs under BLA 125300

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125300
Product	Strength	Form · route	Labeler	Product NDC
Menveomeningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine	Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen 10 ug/.5mL + 3 more ingredients	Injection, SolutionIntramuscular	GlaxoSmithKline Biologicals SA	58160-827